CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 83,640 shares, a decline of 82.8% from the August 31st total of 485,040 shares. Based on an average daily volume of 7 shares, the short-interest ratio is currently 11,948.6 days.
CanSino Biologics Price Performance
OTCMKTS CASBF remained flat at C$2.95 during trading on Friday. The firm’s fifty day moving average price is C$3.61 and its two-hundred day moving average price is C$3.52. CanSino Biologics has a 12-month low of C$2.60 and a 12-month high of C$6.99.
About CanSino Biologics
CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development and commercialization of vaccine products. Headquartered in Tianjin, the company leverages an adenovirus vector platform to develop single-dose and recombinant vaccines targeting a range of infectious diseases. CanSino’s pipeline includes its authorized COVID-19 vaccine, Convidecia (Ad5-nCoV), as well as candidates for Ebola, influenza and other pathogens.
Since its founding in 2009, CanSino has built end-to-end capabilities spanning antigen discovery, process development and large-scale manufacturing.
Featured Stories
- Five stocks we like better than CanSino Biologics
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
